# People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug

> **Open Intelligence Dossier** · First detected: 2026-09-29 23:20 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug&quot; is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo, Scientific American, Ars Technica and The Guardian. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| CNBC | Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxQVWRJUGpFMTlSRTlRTURBdE8wRU5BMkx0UWVqRjhxc01XTnhxNnlCY1VjX1NSblBqeV9rd0lPRlNtTEZ3NVRCd3pqaVZnMmxxZlNVZVN3TmVYa19rd3JlSkU2dERfcU43VzRWdGxHcm9KWUJncE5aSmFRWVR5UlhiR2NCTWZtTUZ4TFBzaVRtTVRnNlVSLVVpZ1J3dUrSAaIBQVVfeXFMTmxiaTFWYXQtWUxiTXQtbGZnRzVMdmdwZGxvS25aNXJNQ1JxeVRaU2xGcXVZbUZoQ2dJaVdDRHVQS296Umdsb0U3OVhmZG96ZWhtSUlOQndxckdTUVNHSFVKNHdJbWxsa0RSaVJKemFETVNaVlNPU1RIVldHeGg1Z21nbGVqcGdpM2pmaEhpSlkzNU5JTzFORWZDTzIwaFNRM2RR?oc=5) |
| Yahoo | Experimental weight loss drug yields big results, but not yet FDA approved | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxPTmNZNmRLWXZ3cVpOVGtQT0d3dEc5ZjAzWC1nQ21NWlk2RE1ubkk1UzBmQmNyZnhaQmlNbkNPSXA5dXRCUHIzek02c2p5Snd3Z1gxU0lTY2F6ZlpGOXlSQzE1RHlmVTg2djZMSnV5Mnh1ZWxIUVNSMVV0dXQ1T2VJalNHNmwzRzlVeHNjY1V3?oc=5) |
| Endpoints News | Lilly's triple-G allows more than half of patients to drop below obesity line | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxPZ3pWLUJxeWkwX3V3NWRMVDZYaG9hUW5RWi04TzJ1YlJENE00Q1FxajBFYXppeGdGVS13NXc0QUN3TnN1LXo5eERfUU1aOXJSRE1kMjdncTdVLXF1VWE5UTZOUEQ3ZzJYZkhqLWdpM0kzQktUbTRhWEVNTk9wWjVyWkU0S1RxV2FSZDgwcXlDcWx3ek1KTTRUZjBYclgydk5nY2c?oc=5) |
| qz.com | Eli Lilly retatrutide sheds 21% body weight in diabetes trial | [Source Link](https://news.google.com/rss/articles/CBMiekFVX3lxTE15WG5kZGxqSldKUjhfMmdFUFRYSEdlRHNkMmNtMC1Ra3I3bktBRHQ4eDZhREdmY295emdNTmJtamhDREgzRUpYZExEQ2I0Yy1sbzZRejlfa1RYeWUwd0hweE12V0JfRVBKcFM3bGcxZEdXUjQ3el9EZzV3?oc=5) |
| Time Magazine | Eli Lilly’s Experimental Weight-Loss Drug Shows Promising Results | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxPRFRPNGJYOF85RWNQYUpGTGp5UW15UlNwUGdsanNzak9nbWM0aU5VdElvNk1SLTRXOHpPX1lUUC00aVp6bTc5UWNEc3Nwd054SmpnSzJOM1o2ZER2STR1bEN5UGRRR0s4Vmk5UkRVUXpnNXBXSHA0QkR6YTN3TDNGcE1CWk9KV1NCdUIzMl9NTmYxUkp4bndBS3o0dzBWMF93X2ozLXNUM0tVTzUtVTZ6Qg?oc=5) |
| fiercebiotech.com | Lilly sets up next-gen obesity battle with full phase 3 retatrutide data | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxQMWNUU241eVI3SFNRcEZJTkpEOElEUkFPcG5qQjBVQnh6ZDJrWGR6S29ycEtWSVJSWUtjQlBhQzNsb3JnQXYyanh2bFBVbGswamczY1hKQ3dvSzNzckg1WGhlZUtRcElxYThtdThlYWRoVXo1R3g2Uk9aZ2IzcTkwLXRYcC1jdmF4bHBTLWE2Zm5mMzZoY24zeXVYXy10UkxGVjBKeG1IMThOQQ?oc=5) |
| Yahoo | Lilly's experimental drug cuts weight by 21% in diabetes trial | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxQV2ZtMWpQRWp2M1dPR1VZdmZyMEtxcC1qMXE0dTZSMDFFRHVaX0JacHJZSzkzcV9DakpFZV8zSi1kWEZBS05TaEVNUzVVYnMwQWhERDZLck9DVW1RVkFCYk5BTk12YTB5OFFkWGxxVWk4NUNVaE1uc3NVZHRYRlZPQUlGWWQzTjFiMkRvUHpfXzN3TzdITTYyeE5tVQ?oc=5) |
| Scientific American | Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs | [Source Link](https://news.google.com/rss/articles/CBMiwwFBVV95cUxOb25xR3djUTZrOHZrOWc3em9vZ0IxRU51R1I5M2xoVUZBdXlYVnZCOEEtOUpNUnBSOWdiWnRyTzJlT1ZBV0JqRkl1cUtPZjBzclhISEhrZ25SRFlVVTQyVzNMRnVfYzNqeHVMWjloU1o0NzZNTTJ4T2tqaVIxVlpRU3R1Vkt1c3VYcl9GRWVOODIzaHM0bUdNYkVGcXpfSHBaWnd0blRxb2FMYUc2Vi01Qnk5dXVZREZkMnZDTFNpSEVtdlE?oc=5) |
| Ars Technica | Most powerful obesity drug yet: People lost up to 25% of weight in trial | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxObVpuTk1WdFNQOHJ4VkZpYVFZTmVvXzVZcm1JcWJKT3dlNS01ckhWaTRIRW9HSHpHaDRsZDJrc2xhV2w4U08zWUdfbDg0elpianB1c1VXT1Jxa1d6SUh0TzJIdGpQYUJ1UHlEYmFHdkVBd3dEZTZNaGJXY0VIM0E3WUREOHhvY015Z0lseXZubHRRX0tnZzJ0bW1GTzROT3pFTGQzVFp1UWhQSnlhMmtR?oc=5) |
| The Guardian | ‘Godzilla’ of weight-loss drugs could provide other important health benefits | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxNZjU0dVc4YkpBc242NkRGT00xZVZLR0dRaUlweTQyY2dFa3NVaVVldk44U1JFcjVwYzFqWFp4NVg5eWxZbGM3OVdSNE9qWTNCaFNNZEFQUzc1RzhuWUJsZnlTbmFiSVYtVzdWdll3OW42d3ZVaURJQnc3Z2pZR2pmOXhHNWdtWFB2b1pVc05KMTFveWRjUFhOajExQkRfcWw4UWJ4cnRfOWNmbzZvMVVjZw?oc=5) |
| NBC News | People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxONmxNWTJxQ3I5NFJvY213LWtQTzZjMjJfLVQyaG5HeFRxYk1Xcml3aFdOSUE3WEJRWnB6OVlLMm1PYmkzSG5ZdXZFdU1fT2E3T0lWN1g0LXBRNVBJN1psZGs4dkk4T3Zmc3dPWnBmNUJvVW1NYW5xeXRUTXFFNmxQQ2lka3lpT2RNRDJ3eEM4Y3lLRjFubU96N0I3NmFuak01Q0x0eVFLOA?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-09-29/people-with-type-2-diabetes-lost-up-to-60-pounds-on-lilly-s-latest-weight-loss*
